Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹34,538 Cr
Revenue (TTM)
₹6,778 Cr
Net Profit (TTM)
₹779 Cr
ROE
24.3 %
ROCE
21.6 %
P/E Ratio
44.3
P/B Ratio
8.2
Industry P/E
44.5
EV/EBITDA
23.1
Div. Yield
0.3 %
Debt to Equity
0.6
Book Value
₹205
EPS
₹40.5
Face value
10
Shares outstanding
204,360,804
CFO
₹5,223.90 Cr
EBITDA
₹5,619.59 Cr
Net Profit
₹2,843.72 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Narayana Hrud
| -10.7 | -7.6 | -9.8 | 7.1 | 27.9 | 32.5 | 19.0 |
|
BSE Healthcare
| -1.7 | -1.1 | -1.9 | 7.5 | 25.6 | 15.6 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Narayana Hrud
| 44.2 | 5.8 | 58.1 | 18.9 | 42.3 | 37.5 | 60.8 |
|
BSE Mid Cap
| 1.1 | 25.8 | 45.5 | 1.4 | 39.2 | 19.9 | -3.0 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Narayana Hrud
|
1,690.0 | 34,538.0 | 6,777.7 | 782.9 | 16.1 | 21.5 | 44.3 | 8.2 |
| 7,471.0 | 1,07,392.0 | 24,215.2 | 1,820.5 | 11.0 | 21 | 59.6 | 11.2 | |
| 662.0 | 34,286.7 | 4,461.2 | 397.5 | 13.4 | 9.1 | 104.9 | 7.5 | |
| 434.0 | 13,736.8 | 1,976.2 | 160.7 | 14.1 | 6.7 | 109 | 7.0 | |
| 846.0 | 63,843.0 | 8,770.4 | 966.3 | 17.8 | 11 | 66.5 | 6.6 | |
| 570.0 | 8,470.7 | 2,478.2 | 24.7 | 8.4 | 4.2 | 447 | 6.3 | |
| 1,282.0 | 8,393.4 | 1,433.4 | 188.7 | 17.4 | 13.8 | 44.5 | 5.6 | |
| 979.8 | 95,318.6 | 8,140.3 | 1,419.2 | 21.2 | 15 | 67.2 | 9.2 | |
| 1,123.9 | 11,410.7 | 1,613.3 | 259.9 | 23.0 | 17.3 | 44.3 | 7.2 | |
| 673.3 | 6,489.5 | 1,089.4 | 165.1 | 17.4 | 10.2 | 38.8 | 3.7 |
How did MFs fare as anchor investors?
4 min read•By Kumar Shankar Roy
Narayana Hrudayalaya Limited engages in the medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals,... clinics, health centers, diagnostic centres, nursing homes and other related activities. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology services. The company engages in health insurance business. The company was incorporated in 2000 and is headquartered in Bengaluru, India. Read more
Incorporated
2000
Chairman
Devi Prasad Shetty
Managing Director
Emmanuel Rupert
Group
Devi Prasad Shetty
Headquarters
Bengaluru, Karnataka
Website
Looking for more details about Narayana Hrudayalaya Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Narayana Hrudayalaya Ltd is ₹1,690.00 (NSE) and ₹1,690.05 (BSE) as of 18-Mar-2026 IST. Narayana Hrudayalaya Ltd has given a return of 27.92% in the last 3 years.
The P/E ratio of Narayana Hrudayalaya Ltd is 44.34 times as on 18-Mar-2026, a 0 discount to its peers’ median range of 44.50 times.
The P/B ratio of Narayana Hrudayalaya Ltd is 8.24 times as on 18-Mar-2026, a 24 premium to its peers’ median range of 6.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
43.74
|
9.53
|
|
2024
|
33.15
|
9.07
|
|
2023
|
26.08
|
7.42
|
|
2022
|
44.59
|
10.27
|
|
2021
|
0.00
|
7.43
|
The 52-week high and low of Narayana Hrudayalaya Ltd are Rs 2,370.20 and Rs 1,451.05 as of 19-Mar-2026.
Narayana Hrudayalaya Ltd has a market capitalisation of ₹ 34,538 Cr as on 18-Mar-2026. As per SEBI classification, it is a Mid Cap company.
Before investing in Narayana Hrudayalaya Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹33.00
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.